600538 Beihai Gofar Chuanshan Biological

Watchlist

5.44
0.000.00%

Market Closed Dec 13 15:00 CST

2.85BMarket Cap-32.57P/E (TTM)

About Beihai Gofar Chuanshan Biological Company

The company was founded in 1993 and is an enterprise mainly engaged in the wholesale business. The main industries the company operates include pharmaceutical manufacturing and pharmaceutical distribution industries, judicial IVD (in vitro diagnosis) technical services, molecular medical imaging centers, tumor radiotherapy centers, and oncology telemedicine technical services. The company's main products include “Haibao” brand pearl eye drops, pearl powder, pearl layer powder, gastrointestinal relief granules, ethanol disinfectant, etc. Corporate honors: “Best Practice for Listed Companies 2022 Report Performance Briefing”, National Key New Products, National Key New Products, Beihai Guofa Biopesticides Award Certificate, etc.

Company Profile

Short Name-A国发股份

Symbol-A600538

Company NameBeihai Gofar Chuanshan Biological Co., Ltd.

Listing DateJan 14, 2003

Issue Price6.69

Shares Offered45.00M share(s)

FoundedJan 22, 1993

Listed ExchangeSH Stock Exchange

Legal Representativeyedai jiang

Secretaryyong li

Accounting FirmTianjian Certified Public Accountants (Special General Partnership)

Securities Representativeliping li

Legal CounselBeijing Times Jiuhe Law Firm

Employees157

Phone0779-3200619

Office AddressNo. 3 Beibuwan Middle Road, Beihai City, Guangxi Zhuang Autonomous Region

Zip Code536000

Registered AddressNo. 3 Beibuwan Middle Road, Beihai City, Guangxi Zhuang Autonomous Region

Fax0779-3200618

Emailsecurities@gofar.com.cn

Websitehttp://www.gofar.com.cn

Business License450500000008877

BusinessLicense projects: pharmaceutical wholesale; pharmaceutical retail; pharmaceutical production; production of second-class medical devices; production of disinfectants (excluding hazardous chemicals); medical services; real estate development and operation. (Projects requiring approval according to law can only carry out business activities after approval by relevant departments. Specific business projects are subject to the relevant department's approval documents or licenses). General projects: medical research and experimental development; research and development of marine bioactive substance extraction, purification, synthesis technology; investment activities with own funds; technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; non-residential real estate leasing; advertising; sales of arts and crafts and ceremonial goods (other than ivory and its products); sales of class II medical devices; sales of disinfectants (excluding hazardous chemicals). (With the exception of projects subject to approval according to law, business activities are carried out independently in accordance with the law on the basis of a business license).